FDA Drug Application (201152) for VIRAMUNE XR by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number201152
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIRAMUNE XR
Active IngredientNEVIRAPINE



Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.